GLI1 and Ewing sarcoma: Although more than 50 inhibitors of the SHH cascade have been synthetized during recent decades [11,28], such as the SMO receptor inhibitor cyclopamine or Gli inhibitors such as GANT58 and GANT61, none of these specific inhibitors have so far been evaluated on a preclinical model of ES.